BioMarin Pharmaceutical Inc. (LON:0HNC)

BioMarin Pharmaceutical Statistics

Total Valuation

LON:0HNC has a market cap or net worth of GBP 7.64 billion. The enterprise value is 7.04 billion.

Market Cap	7.64B
Enterprise Value	7.04B

Important Dates

The next estimated earnings date is Friday, October 24, 2025.

Earnings Date	Oct 24, 2025
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	192.01M
Shares Outstanding	n/a
Shares Change (YoY)	+0.35%
Shares Change (QoQ)	+0.31%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	178.10M

Valuation Ratios

The trailing PE ratio is 15.93 and the forward PE ratio is 12.03.

PE Ratio	15.93
Forward PE	12.03
PS Ratio	3.42
PB Ratio	1.74
P/TBV Ratio	1.87
P/FCF Ratio	15.07
P/OCF Ratio	13.65
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 9.92, with an EV/FCF ratio of 13.87.

EV / Earnings	14.67
EV / Sales	3.14
EV / EBITDA	9.92
EV / EBIT	11.02
EV / FCF	13.87

Financial Position

The company has a current ratio of 5.56, with a Debt / Equity ratio of 0.10.

Current Ratio	5.56
Quick Ratio	3.34
Debt / Equity	0.10
Debt / EBITDA	0.62
Debt / FCF	0.87
Interest Coverage	78.64

Financial Efficiency

Return on equity (ROE) is 11.62% and return on invested capital (ROIC) is 8.37%.

Return on Equity (ROE)	11.62%
Return on Assets (ROA)	7.50%
Return on Invested Capital (ROIC)	8.37%
Return on Capital Employed (ROCE)	12.88%
Revenue Per Employee	735,568
Profits Per Employee	157,803
Employee Count	3,040
Asset Turnover	0.42
Inventory Turnover	0.44

Taxes

In the past 12 months, LON:0HNC has paid 133.42 million in taxes.

Income Tax	133.42M
Effective Tax Rate	21.76%

Stock Price Statistics

The stock price has decreased by -35.46% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-35.46%
50-Day Moving Average	57.93
200-Day Moving Average	62.06
Relative Strength Index (RSI)	37.49
Average Volume (20 Days)	1,222

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	2.80

Income Statement

In the last 12 months, LON:0HNC had revenue of GBP 2.24 billion and earned 479.72 million in profits. Earnings per share was 2.48.

Revenue	2.24B
Gross Profit	1.83B
Operating Income	636.41M
Pretax Income	613.14M
Net Income	479.72M
EBITDA	697.17M
EBIT	636.41M
Earnings Per Share (EPS)	2.48

Balance Sheet

The company has 1.05 billion in cash and 440.76 million in debt, giving a net cash position of 604.55 million.

Cash & Cash Equivalents	1.05B
Total Debt	440.76M
Net Cash	604.55M
Net Cash Per Share	n/a
Equity (Book Value)	4.40B
Book Value Per Share	22.91
Working Capital	2.28B

Cash Flow

In the last 12 months, operating cash flow was 559.67 million and capital expenditures -52.45 million, giving a free cash flow of 507.22 million.

Operating Cash Flow	559.67M
Capital Expenditures	-52.45M
Free Cash Flow	507.22M
FCF Per Share	n/a

Margins

Gross margin is 81.80%, with operating and profit margins of 28.46% and 21.45%.

Gross Margin	81.80%
Operating Margin	28.46%
Pretax Margin	27.42%
Profit Margin	21.45%
EBITDA Margin	31.18%
EBIT Margin	28.46%
FCF Margin	22.68%

Dividends & Yields

LON:0HNC does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-0.35%
Shareholder Yield	n/a
Earnings Yield	6.28%
FCF Yield	6.64%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

LON:0HNC has an Altman Z-Score of 6.89 and a Piotroski F-Score of 7.

Altman Z-Score	6.89
Piotroski F-Score	7